To combat long-overlooked fungal pathogens, researchers and regulators must embrace innovative science and policy.

Bacteria have evolved to produce natural products that can kill fungi, and these products have been used to develop antifungal drugs for humans. However, resistance is widespread and conventional ...

Only four new antifungal drugs were approved over the last decade. The WHO urges for safer treatments and improved diagnostics, especially in low and middle-income countries, to address this ...